Tirzepatide
Dual-action GIP/GLP-1 receptor agonist offering enhanced weight management support with weekly dosing.
Starting at
Starting at $399/mo
About this treatment
Tirzepatide is a first-in-class medication that activates both GIP and GLP-1 receptors. This dual mechanism may provide enhanced benefits for weight management when combined with a reduced-calorie diet and increased physical activity.
Our clinical team will evaluate your health history and goals to determine if tirzepatide may be appropriate for your weight management journey.
What's included
Ready to start?
Complete a quick questionnaire to see if you qualify.
Start assessmentSafety Information
Tirzepatide is a prescription medication requiring provider evaluation. Side effects may include nausea, diarrhea, and injection site reactions.
View full details
Tirzepatide carries a boxed warning for thyroid C-cell tumors. Not recommended for patients with a history of medullary thyroid carcinoma or MEN 2 syndrome. Common side effects include nausea, diarrhea, decreased appetite, vomiting, and constipation. Discuss all medications and medical conditions with your provider.
How it works
Complete questionnaire
Answer health questions online
Provider review
Licensed physician reviews
Receive treatment
Free delivery to your door
Starting at
Starting at $399/mo